182 related articles for article (PubMed ID: 27609275)
21. Autoimmunity against the ryanodine receptor in myasthenia gravis.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
[TBL] [Abstract][Full Text] [Related]
22. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens.
Zisimopoulou P; Brenner T; Trakas N; Tzartos SJ
Autoimmun Rev; 2013 Jul; 12(9):924-30. PubMed ID: 23537507
[TBL] [Abstract][Full Text] [Related]
23. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
24. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
25. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
26. [Thymectomy and muscle antibodies in myasthenia gravis].
Romi F; Gilhus NE; Aarli JA
Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
28. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
[TBL] [Abstract][Full Text] [Related]
29. Pediatric myasthenia gravis with a combination of AChR and RyR is associated with an earlier onset and lower CSR rate: A cohort study in southwest China.
Liu J; Ma J; Hong S; Jiang L; Li T
Eur J Paediatr Neurol; 2023 Nov; 47():1-5. PubMed ID: 37639776
[TBL] [Abstract][Full Text] [Related]
30. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
31. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.
Skeie GO; Romi F; Aarli JA; Bentsen PT; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():343-50. PubMed ID: 14592894
[TBL] [Abstract][Full Text] [Related]
34. Serological and experimental studies in different forms of myasthenia gravis.
Vincent A; Huda S; Cao M; Cetin H; Koneczny I; Rodriguez Cruz PM; Jacobson L; Viegas S; Jacob S; Woodhall M; Nagaishi A; Maniaol A; Damato V; Leite MI; Cossins J; Webster R; Palace J; Beeson D
Ann N Y Acad Sci; 2018 Feb; 1413(1):143-153. PubMed ID: 29377162
[TBL] [Abstract][Full Text] [Related]
35. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
Romi F; Skeie GO; Gilhus NE; Aarli JA
Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
[TBL] [Abstract][Full Text] [Related]
36. [Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma].
Li YF; Li YH; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):517-9. PubMed ID: 16995304
[TBL] [Abstract][Full Text] [Related]
37. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.
Nemoto Y; Kuwabara S; Misawa S; Kawaguchi N; Hattori T; Takamori M; Vincent A
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):714-8. PubMed ID: 15834033
[TBL] [Abstract][Full Text] [Related]
38. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
39. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
Chen XJ; Qiao J; Xiao BG; Lu CZ
J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
[TBL] [Abstract][Full Text] [Related]
40. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
